BioAdvance Ventures

BioAdvance is a prominent life sciences venture capital firm based in the Mid-Atlantic region, specializing in early-stage investments across the healthcare spectrum. Established in 2002 as an evergreen fund, the organization supports innovative startups in therapeutics, medical devices, diagnostics, research tools, and health information technology. BioAdvance primarily targets companies located in the corridor between New York City and Washington, D.C., providing critical seed and Series A funding. With a portfolio of over 120 companies, the firm has contributed to the development of 12 FDA-approved products and facilitated billions in follow-on capital. Led by a team of experienced scientists, physicians, and investment professionals, BioAdvance focuses on advancing technologies with the potential to significantly improve human health.